Flow Neuroscience Receives FDA Clearance for At-Home Depression Treatment
Flow Neuroscience’s brain stimulation headset has been cleared by the FDA, marking the first non-drug, at-home treatment for depression in the U.S. This offers patients an alternative to traditional medication or in-clinic therapy, making mental health care more accessible.
On stage at FH25
Erin Lee, CEO of Flow Neuroscience, shared insights on these developments during her session at Frontiers Health 2025: Scaling Mental and Brain Health Tech Innovation – Organic Growth and Through M&A. Watch the session here
This milestone reflects what we champion at Frontiers Health: patient-centric innovation that redefines care delivery.